298 related articles for article (PubMed ID: 11844233)
1. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
Hsieh PC; Chandler JP; Bhangoo S; Panagiotopoulos K; Kalapurakal JA; Marymont MH; Cozzens JW; Levy RM; Salehi S
Neurosurgery; 2005 Oct; 57(4):684-92; discussion 684-92. PubMed ID: 16239880
[TBL] [Abstract][Full Text] [Related]
3. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
Cho KH; Hall WA; Lo SS; Dusenbery KE
Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS
J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.
Einstein DB; Wessels B; Bangert B; Fu P; Nelson AD; Cohen M; Sagar S; Lewin J; Sloan A; Zheng Y; Williams J; Colussi V; Vinkler R; Maciunas R
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):668-74. PubMed ID: 22445005
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.
Elaimy AL; Mackay AR; Lamoreaux WT; Demakas JJ; Fairbanks RK; Cooke BS; Lamm AF; Lee CM
World Neurosurg; 2013 Dec; 80(6):872-8. PubMed ID: 23403349
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
[TBL] [Abstract][Full Text] [Related]
9. Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma.
Pouratian N; Crowley RW; Sherman JH; Jagannathan J; Sheehan JP
J Neurooncol; 2009 Sep; 94(3):409-18. PubMed ID: 19330482
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients.
Masciopinto JE; Levin AB; Mehta MP; Rhode BS
J Neurosurg; 1995 Apr; 82(4):530-5. PubMed ID: 7897511
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.
Souhami L; Seiferheld W; Brachman D; Podgorsak EB; Werner-Wasik M; Lustig R; Schultz CJ; Sause W; Okunieff P; Buckner J; Zamorano L; Mehta MP; Curran WJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):853-60. PubMed ID: 15465203
[TBL] [Abstract][Full Text] [Related]
14. The role of Gamma Knife Radiosurgery in the management of unresectable gross disease or gross residual disease after surgery in ependymoma.
Lo SS; Abdulrahman R; Desrosiers PM; Fakiris AJ; Witt TC; Worth RM; Dittmer PH; Desrosiers CM; Frost S; Timmerman RD
J Neurooncol; 2006 Aug; 79(1):51-6. PubMed ID: 16557349
[TBL] [Abstract][Full Text] [Related]
15. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.
Kondziolka D; Flickinger JC; Bissonette DJ; Bozik M; Lunsford LD
Neurosurgery; 1997 Oct; 41(4):776-83; discussion 783-5. PubMed ID: 9316038
[TBL] [Abstract][Full Text] [Related]
17. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme.
Shrieve DC; Alexander E; Wen PY; Fine HA; Kooy HM; Black PM; Loeffler JS
Neurosurgery; 1995 Feb; 36(2):275-82; discussion 282-4. PubMed ID: 7731507
[TBL] [Abstract][Full Text] [Related]
18. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
19. [Value of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature].
van Kampen M; Engenhart-Cabillic R; Debus J; Fuss M; Rhein B; Wannenmacher M
Strahlenther Onkol; 1998 Apr; 174(4):187-92. PubMed ID: 9581178
[TBL] [Abstract][Full Text] [Related]
20. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]